Covered recipient · General Payments record
ANSA ANDERSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2025
$3,877.32
- Reported across 203 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $328.39 | 12 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $181.84 | 5 |
| ABBVIE INC. | $55.16 | 2 |
| PFIZER INC. | $19.83 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.31 | 1 |
| Axsome Therapeutics, Inc. | $18.86 | 1 |
| Lilly USA, LLC | $17.97 | 1 |
| Currax Pharmaceuticals LLC | $15.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.76 | 03/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201415016 | CMS |
| ABBVIE INC. | $28.40 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201415018 | CMS |
| Axsome Therapeutics, Inc. | $18.86 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235446853 | CMS |
| Currax Pharmaceuticals LLC | $15.42 | 02/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242701200 | CMS |
| Lilly USA, LLC | $17.97 | 03/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186509655 | CMS |
| Novo Nordisk Inc | $17.60 | 01/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188307709 | CMS |
| Novo Nordisk Inc | $104.70 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188218458 | CMS |
| Novo Nordisk Inc | $22.58 | 04/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188795484 | CMS |
| Novo Nordisk Inc | $22.82 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188391600 | CMS |
| Novo Nordisk Inc | $14.14 | 09/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188298322 | CMS |
| PFIZER INC. | $19.83 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230030143 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.31 | 03/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223851520 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2020, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.